Saudi Arabia Clinical Trials Market Size & Outlook
Global Market
Related Markets
Saudi Arabia clinical trials market highlights
- The Saudi Arabia clinical trials market generated a revenue of USD 177.5 million in 2025 and is expected to reach USD 313.1 million by 2033.
- The Saudi Arabia market is expected to grow at a CAGR of 7.6% from 2026 to 2033.
- In terms of segment, phase iii was the largest revenue generating phase in 2025.
- Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
Clinical trials market data book summary
| Market revenue in 2025 | USD 177.5 million |
| Market revenue in 2033 | USD 313.1 million |
| Growth rate | 7.6% (CAGR from 2026 to 2033) |
| Largest segment | Phase iii |
| Fastest growing segment | Phase I |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase II, Phase III, Phase IV, Phase I |
| Key market players worldwide | Thermo Fisher Scientific Inc, Icon PLC, Charles River Laboratories International Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, PAREXEL, Wuxi AppTec Co Ltd, Labcorp Holdings Inc, Eli Lilly and Co, Novo Nordisk A/S ADR, Pfizer Inc, Caidya |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.2% of the global clinical trials market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Middle East & Africa, South Africa clinical trials market is projected to lead the regional market in terms of revenue in 2033.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 206.4 million by 2033.
Saudi Arabia has the beneficial clinical trial market in the Middle East. The country's market growth can be attributed to the largest number of hospitals, growing incidences of oncology & infectious diseases, and the presence of primary health centers.
Furthermore, growing trial awareness is expected to further boost the demand for recruitment and retention services in Saudi Arabia. As a result, clinical trials are gaining importance in Saudi Arabia for innovating medication and devices for the treatment of various disorders.
Moreover, major upcoming projects aim at developing hospitals such as King Khaled Medical City, King Faisel Medical City, and King Abdullah Medical City, which are expected to give research facilities. This expansion is expected to open new avenues for market players in Saudi Arabia.
No credit card required*
Publish Date: Oct 24, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Clinical Trials Market Scope
Clinical Trials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Pfizer Inc | View profile | 88,000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | www.pfizer.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Charles River Laboratories International Inc | View profile | 21,400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | www.criver.com |
| Labcorp Holdings Inc | View profile | 67,000 | 358 South Main Street, Burlington, NC, United States, 27215 | www.labcorp.com |
| Eli Lilly and Co | View profile | 43,000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | www.lilly.com |
| Novo Nordisk A/S ADR | View profile | 66,015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | www.novonordisk.com |
| Icon PLC | View profile | 41,150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | www.iconplc.com |
| Wuxi AppTec Co Ltd | View profile | 41,116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | www.wuxiapptec.com |
| IQVIA Holdings Inc | View profile | 87,000 | 2400 Ellis Road, Durham, NC, United States, 27703 | www.iqvia.com |
| SGS AG | View profile | 103,193 | 1 Place des Alpes, P.O. Box 2152, Geneva, Switzerland, CH-1211 | www.sgs.com |
Saudi Arabia Clinical Trials Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Clinical Trials Market Outlook will help companies and investors design strategic landscapes.
Phase Iii was the largest segment with a revenue share of 56.34% in 2025.
Horizon Databook has segmented the Saudi Arabia clinical trials market based on phase ii, phase iii, phase iv, phase i covering the revenue growth of each sub-segment from 2021 to 2033.
Saudi Arabia has the beneficial clinical trial market in the Middle East. The country's market growth can be attributed to the largest number of hospitals, growing incidences of oncology & infectious diseases, and the presence of primary health centers.
Furthermore, growing trial awareness is expected to further boost the demand for recruitment and retention services in Saudi Arabia. As a result, clinical trials are gaining importance in Saudi Arabia for innovating medication and devices for the treatment of various disorders.
Moreover, major upcoming projects aim at developing hospitals such as King Khaled Medical City, King Faisel Medical City, and King Abdullah Medical City, which are expected to give research facilities. This expansion is expected to open new avenues for market players in Saudi Arabia.
- Saudi Arabia Clinical Trials Market Phase Outlook (Revenue, USD Million , 2021-2033)
- Phase I
- Phase II
- Phase III
- Phase IV
- Saudi Arabia Clinical Trials Market Study Design Outlook (Revenue, USD Million , 2021-2033)
- Interventional Trials
- Observational Trials
- Expanded Access Trials
- Saudi Arabia Clinical Trials Market Indication Outlook (Revenue, USD Million , 2021-2033)
- Autoimmune/Inflammation
- Pain management
- Oncology
- CNS conditions
- Diabetes
- Obesity
- Cardiovascular
- Others
- Saudi Arabia Clinical Trials Market Service Type Outlook (Revenue, USD Million , 2021-2033)
- Protocol Designing
- Site Identification
- Patient Recruitment
- Laboratory Services
- Analytical Testing Services
- Clinical Trial Data Management Services
- Others
- Saudi Arabia Clinical Trials Market Sponser Outlook (Revenue, USD Million , 2021-2033)
- Pharmaceutical & Biopharmaceutical Companies
- Medical Device Companies
- Others
Reasons to subscribe to Clinical Trials Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Clinical Trials Market Outlook databook
- Our clientele includes a mix of Clinical Trials Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia Clinical Trials Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia Clinical Trials Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Saudi Arabia Clinical Trials Market, 2021-2033 (US$M)
Saudi Arabia clinical trials market statistics, by phase, 2021-2033 (US$M)
